Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

Dairy Industry

Speed and accuracy of quality assurance is vital in the dairy industry. Actiphage is a simple, rapid and sensitive test for MAP in milk or blood that provides results in hours, reducing uncertainty.

Loading...

New research explains MAP found in pasteurised milk

A new highly sensitive test has found 10 per cent of milk samples contain low levels of the pathogen, according...

Actiphage is a new diagnostic from PBD Biotech that provides a rapid, highly specific and sensitive assay for the cost-effective detection of live mycobacteria in blood and milk. 

Mycobacteria are the cause of a number of diseases in cattle and other species, such as bovine TB and Johne’s disease, which not only affect animal health but have a significant economic impact on the dairy industry. Hence the need for regular blood and milk testing, to detect, monitor and manage herd-level infection.

Bulk milk testing with Actiphage can detect 1-2 cells in 50ml of milk providing a high level of confidence in the quality of milk. Results are available in hours enabling the rapid detection and identification of infected herds and individuals.

A survey* of retail purchased semi-skimmed pasteurised milk for MAP showed that 10% contained viable cells, showing it can evade pasteurisation.

Actiphage has been successfully used to detect live mycobacteria in raw milk, pasteurised milk, powdered infant formula, cheese and in the blood of infected animals.

International trials of Actiphage are underway.

Bulk milk testing for MAP

PBD Biotech provides a bulk milk testing service for MAP. Contact us to find out more.

  1. Gerrard Z.E. et al, 'Survival of Mycobacterium avium subspecies paratuberculosis in retail pasteurised milk', Food Microbiology (2018), 74, 57-63

Suspending service

PBD Biotech has announced that is focusing its efforts on developing Actiphage as a rapid blood test for Human Tuberculosis (TB) and will be suspending its commercial Johne’s Testing in blood and MAP testing in bulk milk service (from January 2023) More information.

Please contact us if you would like to discuss this further.

Related content

Loading...
See PBD Biotech at The Dairy Show

5 October 2022

See us at The Dairy Show

September 6, 2022
Ensuring consumer confidence in dairy products has never been more vital and we are delighted to have the opportunity to talk about our new blood test and bulk milk test with producers, cheesemakers, dairy companies and others across the industry...
See PBD Biotech at The Dairy Show

5 October 2022

See us at The Dairy Show

September 6, 2022
Ensuring consumer confidence in dairy products has never been more vital and we are delighted to have the opportunity to...
Johnes Disease testing service

Is there Johne’s Disease in the herd? PBD’s new testing service provides yes/no answer

April 7, 2022
A new rapid testing service from PBD Biotech will enable farmers to find out in days if a bulk milk or blood sample contains MAP, the bacteria that causes Johne's Disease an economically devastating disease.
Johnes Disease testing service

Is there Johne’s Disease in the herd? PBD’s new testing service provides yes/no answer

April 7, 2022
A new rapid testing service from PBD Biotech will enable farmers to find out in days if a bulk milk...
Johnes Disease testing service

7th April 2022, Stoneleigh Park, CV8 2LH

Dairy-Tech 2022 PBD Biotech to launch new Johne’s Disease testing service

April 1, 2022
PBD Biotech to launch at Dairy-Tech, a new rapid test that will enable farmers to find out in days if a bulk milk or blood sample contains MAP, the cause of Johne's Disease
Johnes Disease testing service

7th April 2022, Stoneleigh Park, CV8 2LH

Dairy-Tech 2022 PBD Biotech to launch new Johne’s Disease testing service

April 1, 2022
PBD Biotech to launch at Dairy-Tech, a new rapid test that will enable farmers to find out in days if...

Actiphage shows benefits for quality assurance in milk

January 26, 2022
Johne's Disease, is a wasting disease caused by MAP. A sensitive test for assessing milk samples would be a useful quality assurance tool.

Actiphage shows benefits for quality assurance in milk

January 26, 2022
Johne's Disease, is a wasting disease caused by MAP. A sensitive test for assessing milk samples would be a useful...
1 2 3 Next »

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More